Picture EBD Group BIO-Europe 2024 Stockholm from 14 Sep 650x100px

Organisation › Details

Boehringer Ingelheim Animal Health (division)

https://www.boehringer-ingelheim.com/animal-health/overview

As the second largest animal health business in the world, Boehringer Ingelheim is committed to improving animal health. With more than 10,000 employees worldwide, Boehringer Ingelheim Animal Health has products available in more than 150 markets and a global presence in 99 countries. *

	Start	2018-04-11 existent
	Group	Boehringer Ingelheim (Group)
	Industry	animal health
	Industry 2	animal vaccine

	Region	Ingelheim
	Country	Germany
	City	n. a.
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2024-09-06

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for Boehringer Ingelheim (Group)

[1] Boehringer Ingelheim Stiftung / ÖAW. (9/18/24). "Press Release: OeAW and Boehringer Ingelheim Foundation Establish New Institute for Biomedical Artificial Intelligence in Vienna". Mainz....
[2] Boehringer Ingelheim. (9/3/24). "Press Release: Boehringer Ingelheim Acquires Saiba Animal Health, Adding Innovative Technology Platform to Its Pet Therapeutics R&D Portfolio". Ingelheim....
[3] Boehringer Ingelheim. (8/30/24). "Press Release: Boehringer Ingelheim Announces Appointments Board of Managing Directors". Ingelheim....
[4] Boehringer Ingelheim. (8/27/24). "Press Release: Boehringer Ingelheim to Unveil Groundbreaking oncology Research at WCLC, Demonstrating Strength of Portfolio". Ingelheim....
[5] Shenzhen Synthetica Pioneering Co., Ltd.. (7/30/24). "Press Release: Synthetica Pioneering Closes a Series A Funding Round to Support Development of Oncolytic Bacterial Therapy for Solid Tumors". Shenzhen....
[6] Boehringer Ingelheim. (7/29/24). "Press Release: CHMP Adopts Positive Opinion Recommending Approval of New and Expanded Indications for Spevigo". Ingelheim & La Jolla, CA....
[7] Boehringer Ingelheim. (7/29/24). "Press Release: Boehringer Ingelheim Secures Novel Immune Checkpoint Inhibitor with Acquisition of Nerio Therapeutics". Ingelheim & La Jolla, CA....
[8] Quantro Therapeutics GmbH. (6/4/24). "Press Release: Quantro Therapeutics Reaches a Milestone in the Collaboration with Boehringer Ingelheim to Develop First-in-Class Cancer Treatments". Vienna....
[9] PhoreMost Ltd.. (6/3/24). "Press Release: PhoreMost Achieves Second Milestone in Target Discovery Alliance with Boehringer Ingelheim". Cambridge....
[10] Boehringer Ingelheim. (5/22/24). "Press Release: Boehringer Ingelheim and OSE Immunotherapeutics Expand Collaboration to Develop First-in-class Treatments for Cancer and Cardio-renal-metabolic Diseases". Ingelheim & Nantes....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]